Hostname: page-component-745bb68f8f-g4j75 Total loading time: 0 Render date: 2025-02-10T08:00:38.063Z Has data issue: false hasContentIssue false

Non-syndromic hereditary sensorineural hearing loss: review of the genes involved

Published online by Cambridge University Press:  14 January 2014

F Stelma*
Affiliation:
MRC Harwell, Harwell Science and Innovation Campus, Didcot, UK Department of Otorhinolaryngology, University of Groningen, University Medical Centre Groningen, The Netherlands
M F Bhutta
Affiliation:
MRC Harwell, Harwell Science and Innovation Campus, Didcot, UK Nuffield Department of Surgical Sciences (University of Oxford) and Department of Otolaryngology Head and Neck Surgery, John Radcliffe Hospital, Oxford, UK
*
Address for correspondence: Dr F Stelma, MRC Harwell, Harwell Science and Innovation Campus, Didcot OX11 0RD, UK Fax: +44 (0) 1235 841172 E-mail: femkestelma@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Background:

Hereditary sensorineural hearing loss is the most frequently occurring birth defect. It has profound effects for the individual and is a substantial burden on society. Insight into disease mechanisms can help to broaden therapeutic options and considerably lower lifetime social costs. In the past few decades, the identification of genes that can cause this type of hearing loss has developed rapidly.

Objective:

This paper provides a concise overview of the currently known genes involved in non-syndromic hereditary hearing loss and their function in the inner ear.

Type
Review Articles
Copyright
Copyright © JLO (1984) Limited 2014 

Introduction

Congenital hearing impairment affects approximately 3 in every 1000 live births and is the most frequent birth defect in developed countries.Reference White1 Children born with hearing impairment encounter challenges in speech development, education and language acquisition. This results in decreased opportunities for the individual and a potential burden on society. It has been estimated that the lifetime social costs of untreated hearing loss can reach up to US $1.1 million per individual. Treatment and early intervention could decrease these costs by 75 per cent.Reference Keren, Helfand, Homer, McPhillips and Lieu2

More than 50 per cent of congenital sensorineural hearing impairment is hereditary and caused by genetic mutations.Reference Smith, Bale and White3 Hearing loss can either be syndromic, as part of multiple anomalies throughout the body, or non-syndromic, being restricted to the inner ear. Non-syndromic hearing loss can be further categorised by mode of inheritance. In the largest fraction of cases (80 per cent), inheritance is autosomal recessive (often labelled ‘DFNB’). This type of hearing loss is generally congenital, although some forms may present later in life. In the other 20 per cent of cases, inheritance of hearing loss is autosomal dominant (‘DFNA’). In this type there is usually a delayed onset of hearing loss. The rest of non-syndromic hearing loss is either X-linked or mitochondrial (less than 1 per cent).Reference Morton4

Insight into the genes involved in congenital hearing loss and the underlying mechanisms may enable targeted genetic counselling and treatment. Screens for specific genetic mutations can be performed based on clinical features such as mode of inheritance, morphological appearance, and onset and progression of hearing loss. Genes that are a common cause of hearing loss, such as GJB2, SLC26A4 and OTOF, are frequently included in diagnostic tests.Reference Hilgert, Smith and Van Camp5 The results can be used to counsel parents about the prognosis of hearing loss in their child, the chance of recurrence in future offspring and the predicted outcomes of therapeutic options like cochlear implantation. For example, the outcome of cochlear implantation in syndromic hearing loss is less predictable than in non-syndromic hearing loss. Patients with isolated mutations in the gene GJB2 have speech outcomes that are better than average, whereas patients with cochleovestibular dysplasia fare worse than average.Reference Pakdaman, Herrmann, Curtin, Van Beek-King and Lee6, Reference Black, Hickson, Black and Perry7 The presence of auditory nerve malformation or neuropathy also predicts inferior results.Reference Rance and Barker8, Reference Breneman, Gifford and Dejong9 A better understanding of underlying pathophysiology will enable us to better assess cochlear implant candidacy.

More importantly, there is the potential to exploit knowledge of underlying genetic mutations to prevent or ameliorate hereditary hearing loss. Gene therapy utilises viral vectors delivered to the inner ear to replace the defective gene with a normal copy of the gene. There are promising early results from animal studies: adenovirus-delivered SLC17A8 (VGLUT3, vesicular glutamate transporter 3) restores hearing in mice lacking this gene.Reference Akil, Seal, Burke, Wang, Alemi and During10 It may also be possible to use gene therapy to recover hair cell degeneration: delivery of the ATOH1 gene product has been found to induce hair cell development and regeneration.Reference Lustig and Akil11

This review provides an overview of the currently known genes involved in non-syndromic hereditary hearing loss (Table I).

Table I Genes associated with non-syndromic hearing loss

DFNA = non-syndromic deafness, autosomal dominant; DFNB = non-syndromic deafness, autosomal recessive; TM = tectorial membrane; Ca2+ calcium ion; K+ = potassium ion

Hearing mechanism

We begin with a brief review of the mechanism of human hearing. The cochlea is the auditory portion of the inner ear and is a spiral structure containing three compartments: the scala vestibuli and scala tympani, which are filled with perilymph, and the scala media which is filled with endolymph (Figure 1c). The organ of Corti is located within the middle compartment, the scala media, and includes the inner hair cells, which detect sound (Figure 1d). Airborne sound waves are transmitted through the external and middle ear to the oval window of the cochlea (Figure 1a). Displacement of the oval window causes a wave in the fluids of the cochlea (Figure 1b), leading to displacement of the basilar membrane. Inner hair cells attached to the basilar membrane carry on their apical surface numerous finger-like projections called stereocilia, which will deflect upon physical vibration and move relative to one another. This movement is thought to cause the opening of specific ion channels, a mechanism called mechanotransduction.Reference Dror and Avraham12 Opening of these channels initiates an influx of potassium and calcium ions which depolarises the hair cell. This leads to calcium-dependent exocytosis of neurotransmitter vesicles at the cell's basolateral surface in an area called the synaptic ribbon.Reference Hudspeth13 The release of neurotransmitters excites adjacent auditory neurons which signal to auditory centres in the brain, contributing to the perception of sound.

Fig. 1 Anatomical diagrams of the human ear, showing: (a) the outer ear, middle ear and inner ear; (b) a cross section of the cochlea; (c) the three compartments of the cochlea; and (d) the organ of Corti. OHC = outer hair cell

The organ of Corti also contains outer hair cells; the stereocilia of these hair cells are connected to the overlying tectorial membrane.Reference Legan, Lukashkina, Goodyear, Lukashkin, Verhoeven and Van Camp14 Whereas the inner hair cells function as sensory players, capturing information about the frequency, intensity and timing of sound, the outer hair cells function as cochlear amplifiers, changing the sensitivity and selectivity to sound.Reference Brownell, Bader, Bertrand and de Ribaupierre15

The structure and physiology of the inner ear is in many ways unique and unmatched at other anatomical locations. This explains why so many genes are thought to be involved in inner-ear function and why the ear is so sensitive to mutation at these loci. Mutations in genes that control the cytoskeleton of hair cells, the adhesion of hair cells, intracellular transport, neurotransmitter release or ionic homeostasis can all lead to malfunction of the cochlea (Figure 2).

Fig. 2 Diagrammatic representation of important structural proteins in mature hair cell stereocilia. CEACAM16 = carcinogenic antigen-related cell adhesion molecule 16; TRIOBP = trio-binding protein; SMPX = small muscle protein, X-linked; TMC = tectorial membrane attachment crown; TL = tip link; HT = horizontal top connector

Cytoskeleton

As described in the introduction, hair cells have a characteristic shape, with linear, microvilli-like projections called stereocilia arising from their apical surface. The bundles are aligned in a ‘V’ shape and ranked in increasing height. A number of the genes involved in the organisation of the cytoskeleton can cause non-syndromic hearing loss. These include ACTG1 (γ-actin), DIAPH1 (diaphanous 1), TRIOBP (trio-binding protein), TPRN (taperin), SMPX (small muscle protein, X-linked), ESPN (espin) and RDX (radixin).

It is known that γ-actin functions as the building block of hair cell stereocilia. These stereocilia are constantly undergoing actin polymerisation at the tip and depolymerisation at the base.Reference Rzadzinska, Schneider, Davies, Riordan and Kachar16 Mutations in ACTG1 can interfere with this process and cause autosomal dominant hearing loss, DFNA20/26.Reference van Wijk, Krieger, Kemperman, De Leenheer, Huygen and Cremers17, Reference Zhu, Yang, Wei, DeWan, Morell and Elfenbein18 Other proteins are important in this constant remodelling process. For instance, diaphanous 1 regulates the polymerisation and reorganisation of actin monomers into polymers, and has been associated with autosomal dominant hearing loss (DFNA1).Reference Lynch, Lee, Morrow, Welcsh, Leon and King19 The organisation and binding of γ-actin at the base (the so-called ‘taper region’) of hair cell stereocilia is regulated by two alternative splice isoforms of the TRIOBP gene.Reference Kitajiri, Sakamoto, Belyantseva, Goodyear, Stepanyan and Fujiwara20 Mutations in these isoforms, TRIOBP4 and TRIOBP5, form the origin of DFNB28.Reference Riazuddin, Khan, Ahmed, Ghosh, Caution and Nazli21, Reference Shahin, Walsh, Sobe, Abu Sa'ed, Abu Rayan and Lynch22 Another protein localised at this taper region is the regulating protein taperin, which is associated with DFNB79.Reference Rehman, Morell, Belyantseva, Khan, Boger and Shahzad23 The X-linked gene SMPX (DFN4) encodes a protein suggested to have a function in stereocilial development and maintenance in response to the repetitive mechanical stress that these stereocilia are subjected to.Reference Huebner, Gandia, Frommolt, Maak, Wicklein and Thiele24, Reference Schraders, Haas, Weegerink, Oostrik, Hu and Hoefsloot25

The protein espin acts as a bundling protein, providing stability to the stereocilial cytoskeleton.Reference Bartles, Wierda and Zheng26 In ‘jerker’ mice that lack espin, stereocilia shorten and merge from postnatal day 11, which is simultaneous with the onset of hearing. The hair cells further degenerate over time, and after three months the whole organ of Corti is degraded, indicating the importance of a well-organised cytoskeleton.Reference Zheng, Sekerkova, Vranich, Tilney, Mugnaini and Bartles27 In humans, mutations in ESPN cause DFNB36Reference Boulouiz, Li, Soualhine, Abidi, Chafik and Nurnberg28, Reference Naz, Griffith, Riazuddin, Hampton, Battey and Khan29 and autosomal dominant hearing loss.Reference Donaudy, Zheng, Ficarella, Ballana, Carella and Melchionda30 More stability is provided by radixin, which is present along the length of the stereocilia and links actin filaments to the plasma membrane.Reference Pataky, Pironkova and Hudspeth31 Mutations in RDX cause recessive deafness, DFNB24.Reference Khan, Ahmed, Shabbir, Kitajiri, Kalsoom and Tasneem32

Adhesion proteins

Throughout their existence, stereocilia are interconnected and linked to the tectorial membrane by a set of different adhesion proteins. During maturation of the hair bundle in the mouse embryo, a set of temporary links maintain stability. These include transient lateral links (or shaft connectors) and ankle links. These links probably function to provide hair bundle integrity during maturation and/or induce signalling complexes needed for growth regulation and arrangement.Reference Goodyear, Marcotti, Kros and Richardson33 In the mature hair bundle, stereocilia are connected by tip links, horizontal top connectors and tectorial membrane attachment crowns (Figure 2). To date, several genes crucial for the linking apparatus have been identified. These include: DFNB31 (WHRN (whirlin)),Reference Mburu, Mustapha, Varela, Weil, El-Amraoui and Holme34 DFNB18 (USH1C (harmonin)),Reference Ouyang, Xia, Verpy, Du, Pandya and Petit35, Reference Ahmed, Smith, Riazuddin, Makishima, Ghosh and Bokhari36 DFNB66/67 (TMHS (tetraspan membrane protein)),Reference Shabbir, Ahmed, Khan, Riazuddin, Waryah and Khan37 DFNB84 (PTPRQ (tyrosine phosphate receptor Q)),Reference Schraders, Oostrik, Huygen, Strom, van Wijk and Kunst38 DFNB16 (STRC (stereocilin)),Reference Verpy, Masmoudi, Zwaenepoel, Leibovici, Hutchin and Del Castillo39 DFNA4 (CEACAM16 (carcinogenic antigen-related cell adhesion molecule 16)),Reference Zheng, Miller, Yang, Hildebrand, Shearer and DeLuca40 DFNB22 (OTOA (otoancorin)),Reference Zwaenepoel, Mustapha, Leibovici, Verpy, Goodyear and Liu41 DFNB23 (PCDH15 (protocadherin 15))Reference Ahmed, Smith, Riazuddin, Makishima, Ghosh and Bokhari36 and DFNB12 (CDH23 (cadherin 23)).Reference Bork, Peters, Riazuddin, Bernstein, Ahmed and Ness42

Whirlin and harmonin are scaffolding proteins that regulate the formation of the link complexes. Through their PDZ domain binding sites (i.e. binding sites for other proteins), scaffolding proteins fulfil their role in organising multi-protein aggregates and assembling signalling complexes.Reference Michalski, Michel, Caberlotto, Lefevre, van Aken and Tinevez43 Mutations in whirlin and harmonin cause autosomal recessive hearing loss. A third scaffolding protein is Sans, which is associated with the complex syndromic hearing loss of Usher syndrome. USH2a and VLGR1b, two other genes associated with Usher syndrome, are part of the stereocilial ankle link.Reference Michalski, Michel, Bahloul, Lefevre, Barral and Yagi44

Cadherin 23 and protocadherin 15, as well as PTPRQ and TMHS, are presumably part of the transient lateral link. They prevent fusion of stereocilia by keeping them at a fixed distance from each other during development.Reference Goodyear, Legan, Wright, Marcotti, Oganesian and Coats45Reference Michel, Goodyear, Weil, Marcotti, Perfettini and Wolfrum47 In the mature hair cell, cadherin 23 and protocadherin 15 become the main components of the tip link. These provide stability and gate the mechanotransduction channel; these tip links provide stability and gate the mechanotransduction channel, which plays a central role in auditory function.Reference Kazmierczak, Sakaguchi, Tokita, Wilson-Kubalek, Milligan and Muller48 TMHS co-localises with protocadherin 15 and is a proposed subunit of the mechanotransduction channel.Reference Shabbir, Ahmed, Khan, Riazuddin, Waryah and Khan37, Reference Xiong, Grillet, Elledge, Wagner, Zhao and Johnson49

Stereocilin is an extracellular protein that is thought to make up both horizontal top connectors and tectorial membrane attachment links. The latter, combined with the so-called attachment crown, attach the tallest stereocilia of the outer hair cell stereocilia bundle to the tectorial membrane.Reference Verpy, Leibovici, Michalski, Goodyear, Houdon and Weil50 This tectorial membrane attachment crown is probably formed by CEACAM16. In a similar way, otoancorin is thought to attach non-sensory cells to the tectorial membrane.Reference Zwaenepoel, Mustapha, Leibovici, Verpy, Goodyear and Liu41

Transport proteins

Motor proteins can be used to transport different proteins to target sites in the cell. In the inner ear, the proteins used for transport are all part of the unconventional myosin family. These proteins can bind to the actin cytoskeleton and move forward along actin filaments by using energy derived from ATP. The carboxyl-terminal tails of the transport protein contain binding sites for the proteins they will carry.Reference Friedman, Dror and Avraham51 Seven unconventional myosins have been associated with hereditary hearing loss: myosin Ia (DNFA48),Reference Donaudy, Ferrara, Esposito, Hertzano, Ben-David and Bell52 myosin IIIa (DFNB30),Reference Walsh, Walsh, Vreugde, Hertzano, Shahin and Haika53 myosin VI (DFNA22/DFNB37),Reference Melchionda, Ahituv, Bisceglia, Sobe, Glaser and Rabionet54, Reference Ahmed, Morell, Riazuddin, Gropman, Shaukat and Ahmad55 myosin VIIa (DFNA11/DFNB2),Reference Liu, Walsh, Tamagawa, Kitamura, Nishizawa and Steel56, Reference Weil, Kussel, Blanchard, Levy, Levi-Acobas and Drira57 non-muscle myosin heavy chain IX (DFNA17)Reference Lalwani, Goldstein, Kelley, Luxford, Castelein and Mhatre58 and XIV (DFNA4),Reference Donaudy, Snoeckx, Pfister, Zenner, Blin and Di Stazio59 and myosin XVa (DFNB3).Reference Wang, Liang, Fridell, Probst, Wilcox and Touchman60 These proteins all have their own unique transport function in the inner-ear hair cells.

Synapse

Otoferlin (OTOF) acts with one of the myosins, myosin VI, at the synaptic cleft of the inner hair cell. The protein is thought to be involved in the (calcium-dependent) fusion of synaptic vesicles to the plasma membrane. As a result, the neurotransmitter glutamate is released into the synaptic cleft with subsequent excitation of the afferent neuron. In OTOF-mutant mice, a reduction in exocytosis is detected.Reference Heidrych, Zimmermann, Kuhn, Franz, Engel and Duncker61 A number of allelic variants of OTOF that cause DFNB9 in humans have been identified.Reference Yasunaga, Grati, Cohen-Salmon, El-Amraoui, Mustapha and Salem62

Another player at the inner hair cell synapse is VGLUT3, a member of the vesicular glutamate receptors. VGLUT3 is encoded by SLC17A8 and associated with autosomal recessive hearing loss DFNA25.Reference Ruel, Emery, Nouvian, Bersot, Amilhon and Van Rybroek63 The protein is thought to regulate the endocytosis and exocytosis of glutamate. Both OTOF and SLC17A8 knockout mice show a reduction in the number of postsynaptic ganglion cells, indicating that these proteins are crucial for the development and preservation of normal hearing.Reference Seal, Akil, Yi, Weber, Grant and Yoo64

Ion homeostasis

The cochlea contains two types of fluids, both different in ion composition. Perilymph is high in sodium and low in potassium, whereas endolymph is high in potassium and low in sodium. This contributes to a highly positive potential (+80 mV) called the endocochlear potential. A potassium influx from the endolymph into the hair cell causes depolarisation of the cell. Immediately after depolarisation, the hair cell repolarises, shifting cations via neighbouring structures back into the endolymph (Figure 3). This process of ion homeastasis involves claudin 14 (CLDN14), tricellulin (MARVELD2/TRIC), tight junction protein 2 (TJP2), a number of connexins (GJB's), KCNQ4 (KCNQ4), ATP2b2 (ATP2b2/PMCA2), Barttin (BSND) and pendrin (SLC26A4) all of which are related to hereditary hearing loss.

Fig. 3 Diagrammatic representation of potassium circulation within the cochlea: the opening of ion channels in the hair cell apical membrane allows a potassium influx from the endolymph into the hair cell; potassium is then moved to supporting cells and pumped back into the endolymph via spiral ligament and stria vascularis gap junction networks. K+ = potassium ion; IHC = inner hair cells; OHC = outer hair cells

Tight junctions guard the border between endolymph and perilymph compartments. By generating a seal between two adjacent cells, a barrier is created that restricts the free diffusion of ions. In this way, the apical side of the outer hair cells and supporting cells are exposed to the endolymph, and the basolateral surface is bathed in cortilymph, a fluid which is similar to perilymph and fills up the so-called space of Nuel. This space of Nuel, which surrounds the basolateral surface of outer hair cells, might change in electric potential when the tight junction protein claudin 14 is absent or dysfunctional, as in DFNB29.Reference Ben-Yosef, Belyantseva, Saunders, Hughes, Kawamoto and Van Itallie65, Reference Wilcox, Burton, Naz, Riazuddin, Smith and Ploplis66 In a similar way, tricellulin, encoded by MARVELD2/TRIC, is presumed to function as tight junction that connects three cells together and causes DFNB49 when mutated.Reference Riazuddin, Ahmed, Fanning, Lagziel, Kitajiri and Ramzan67 TJP2 acts as a scaffolding protein, binding tight junctions to the actin cytoskeleton. Duplication with over-expression of the protein causes DFNA51.Reference Walsh, Pierce, Lenz, Brownstein, Dagan-Rosenfeld and Shahin68 This process occurs as a result of another role of the TJP2 protein, namely its involvement in the nucleus' signaling pathways that regulate the cell cycle. Over-expression of TJP2 disturbs the balance between pro-apoptotic and anti-apoptotic genes and will induce apoptosis.Reference Lenz and Avraham69

A network of gap junctions (channels that extend over two adjacent membranes) in the cochlea enables the exchange of various small molecules and ions. These gap junctions are made up of specialised proteins called connexins, which are expressed in the supporting cells of the organ of Corti and the connective tissue of the spiral ligament.Reference Hoang Dinh, Ahmad, Chang, Tang, Stong and Lin70 This gap junction network is associated with the recycling of potassium ions needed for normal hearing. The first identified gene and most common cause of non-syndromic hearing loss is GJB2, which encodes connexin 26 (DFNA3a/DFNB1a).Reference Kelsell, Dunlop, Stevens, Lench, Liang and Parry71 Mutations in the GJB2 gene account for 30–50 per cent of all cases of childhood deafness, and 1–4 per cent of the average human population are estimated to be carriers.Reference Hoang Dinh, Ahmad, Chang, Tang, Stong and Lin70 Other connexins associated with non-syndromic hearing loss are connexin 31 (GJB3, DFNA2b/DFNB91)Reference Xia, Liu, Tang, Pan, Huang and Dai72, Reference Liu, Xia, Xu, Pandya, Liang and Blanton73 and connexin 30 (GJB6, DFNA3b/DFNB1b).Reference Grifa, Wagner, D'Ambrosio, Melchionda, Bernardi and Lopez-Bigas74, Reference del Castillo, Villamar, Moreno-Pelayo, del Castillo, Alvarez and Telleria75

KCNQ4 encodes a protein that forms a voltage-gated potassium channel. This gene is expressed in the outer hair cells of the cochlea and is mutated in a dominant form of non-syndromic hearing loss, DFNA2a.Reference Kubisch, Schroeder, Friedrich, Lutjohann, El-Amraoui and Marlin76 KCNQ4 is thought to aid repolarisation of the outer hair cells. Furthermore, KCNQ4 is proposed to regulate sensitivity to sound by changing the resting membrane potential of the outer hair cells.Reference Heidenreich, Lechner, Vardanyan, Wetzel, Cremers and De Leenheer77

On their apical surface, in the stereocilial membrane, hair cells express ATP2b2/PMCA2, which is a modifier of DFNB12.Reference Schultz, Yang, Caride, Filoteo, Penheiter and Lagziel78 The protein product PMCA2 is a calcium pump that uses energy from ATP to function. Calcium, which is used (in addition to potassium) to excite the cell, is constantly pumped back into the endolymph by PMCA2, thereby ensuring a stable concentration of this ion.Reference Bortolozzi, Brini, Parkinson, Crispino, Scimemi and De Siati79 PMCA2 fulfils a similar function in the synaptic region on the basolateral surface of the hair cell.

BSND and SLC26A4, which encode barttin and pendrin respectively, are genes involved in both syndromic and non-syndromic hearing loss. Barttin is a chloride channel subunit. Most mutations in BSND cause Bartter syndrome, which comprises hearing loss and renal abnormalities. The molecular basis of DFNB73 has been attributed to a mutation in BSND, which causes non-syndromic deafness.Reference Riazuddin, Anwar, Fischer, Ahmed, Khan and Janssen80 The anion exchanger pendrin plays a major role in maintaining a constant acid–base balance. Both syndromic hearing loss (Pendred's syndrome, associated with goitre) and non-syndromic hearing loss (DFNB4) have been described in relation to this, the occurrence of which depends on the extent of the mutation in SLC16A4.Reference Li, Everett, Lalwani, Desmukh, Friedman and Green81, Reference Everett, Glaser, Beck, Idol, Buchs and Heyman82

Electromotility

The outer hair cells have a unique feature of altering sensitivity and selectivity to sound. The protein Prestin is thought to be responsible for this by introducing a process called electromotility. Prestin changes its configuration in reaction to changes in membrane potential, enabling the outer hair cell length to be altered. In this way, the cylindrical outer hair cell becomes shorter on depolarisation and longer on hyperpolarisation, thereby amplifying its sensitivity to sound.Reference Brownell, Bader, Bertrand and de Ribaupierre15 Prestin, encoded by SLC26A5, was first identified by Zheng et al. in 2000.Reference Zheng, Shen, He, Long, Madison and Dallos83 In homozygous Prestin null mice, cochlear thresholds were found to be 40–60 dB higher than in wild-type mice.Reference Liberman, Gao, He, Wu, Jia and Zuo84 In humans, mutations in SLC26A5 are the cause of DFNB61 hearing loss.Reference Liu, Ouyang, Xia, Zheng, Pandya and Li85

Others

Other important groups of genes involved in hereditary hearing loss that will not be discussed further are extracellular matrix proteins, including TECTA (α-tectorin), COL11A2 (type XI collagen α2) and COCH (cochlin), and a number of transcription factors, including POU4f3 (class 4 POU), POU3f4 (class 3 POU), EYA4 (eyes absent 4), MIR96 (microRNA96), ESRRB (oestrogen-related receptor β) and GRHL2 (grainyhead-like 2).

Conclusion

In the last two decades, our understanding of the basis of hereditary hearing loss has advanced significantly. This has been powered by major developments in human and mouse genetics. Improved genotyping and mapping has enabled the study of human families with multi-generational hereditary hearing loss. This has led to the identification of many genetic mutations that can cause syndromic or non-syndromic deafness. The mouse has proven to be an excellent genetic model for human hearing loss and deafness because of its structural, physiological and genetic similarities. Programmes for the systematic mutationReference Brown, Hardisty-Hughes and Mburu86 and phenotypingReference Hardisty-Hughes, Parker and Brown87 of mice have enabled the discovery of many new genes involved in cochlear embryology or function, and many genetic loci have subsequently been found to underlie human deafness.

In this article, we have given an overview of the currently known genes involved in hereditary hearing loss (Table I). The function of these genes will become better understood with time, and no doubt many more genes that can lead to hearing loss will be discovered. With continued examination, we will build a better understanding of the function of the cochlea, and hopefully develop novel molecular therapies for human sensorineural hearing loss.

Acknowledgement

The authors would like to acknowledge Mr J Stelma for graphic design.

References

1White, KR. Early hearing detection and intervention programs: opportunities for genetic services. Am J Med Genet A 2004;130A:2936Google Scholar
2Keren, R, Helfand, M, Homer, C, McPhillips, H, Lieu, TA. Projected cost-effectiveness of statewide universal newborn hearing screening. Pediatrics 2002;110:855–64CrossRefGoogle ScholarPubMed
3Smith, RJ, Bale, JF Jr, White, KR. Sensorineural hearing loss in children. Lancet 2005;365:879–90Google Scholar
4Morton, NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 1991;630:1631Google Scholar
5Hilgert, N, Smith, RJ, Van Camp, G. Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat Res 2009;681:189–96Google Scholar
6Pakdaman, MN, Herrmann, BS, Curtin, HD, Van Beek-King, J, Lee, DJ. Cochlear implantation in children with anomalous cochleovestibular anatomy: a systematic review. Otolaryngol Head Neck Surg 2012;146:180–90Google Scholar
7Black, J, Hickson, L, Black, B, Perry, C. Prognostic indicators in paediatric cochlear implant surgery: a systematic literature review. Cochlear Implants Int 2011;12:6793Google Scholar
8Rance, G, Barker, EJ. Speech perception in children with auditory neuropathy/dyssynchrony managed with either hearing aids or cochlear implants. Otol Neurotol 2008;29:179–82CrossRefGoogle ScholarPubMed
9Breneman, AI, Gifford, RH, Dejong, MD. Cochlear implantation in children with auditory neuropathy spectrum disorder: long-term outcomes. J Am Acad Audiol 2012;23:517Google Scholar
10Akil, O, Seal, RP, Burke, K, Wang, C, Alemi, A, During, M et al. Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron 2012;75:283–93Google Scholar
11Lustig, LR, Akil, O. Cochlear gene therapy. Curr Opin Neurol 2012;25:5760Google Scholar
12Dror, AA, Avraham, KB. Hearing loss: mechanisms revealed by genetics and cell biology. Annu Rev Genet 2009;43:411–37Google Scholar
13Hudspeth, AJ. How hearing happens. Neuron 1997;19:947–50Google Scholar
14Legan, PK, Lukashkina, VA, Goodyear, RJ, Lukashkin, AN, Verhoeven, K, Van Camp, G et al. A deafness mutation isolates a second role for the tectorial membrane in hearing. Nat Neurosci 2005;8:1035–42Google Scholar
15Brownell, WE, Bader, CR, Bertrand, D, de Ribaupierre, Y. Evoked mechanical responses of isolated cochlear outer hair cells. Science 1985;227:194–6Google Scholar
16Rzadzinska, AK, Schneider, ME, Davies, C, Riordan, GP, Kachar, B. An actin molecular treadmill and myosins maintain stereocilia functional architecture and self-renewal. J Cell Biol 2004;164:887–97Google Scholar
17van Wijk, E, Krieger, E, Kemperman, MH, De Leenheer, EM, Huygen, PL, Cremers, CW et al. A mutation in the gamma actin 1 (ACTG1) gene causes autosomal dominant hearing loss (DFNA20/26). J Med Genet 2003;40:879–84Google Scholar
18Zhu, M, Yang, T, Wei, S, DeWan, AT, Morell, RJ, Elfenbein, JL et al. Mutations in the gamma-actin gene (ACTG1) are associated with dominant progressive deafness (DFNA20/26). Am J Hum Genet 2003;73:1082–91CrossRefGoogle ScholarPubMed
19Lynch, ED, Lee, MK, Morrow, JE, Welcsh, PL, Leon, PE, King, MC. Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous. Science 1997;278:1315–18CrossRefGoogle ScholarPubMed
20Kitajiri, S, Sakamoto, T, Belyantseva, IA, Goodyear, RJ, Stepanyan, R, Fujiwara, I et al. Actin-bundling protein TRIOBP forms resilient rootlets of hair cell stereocilia essential for hearing. Cell 2010;141:786–98Google Scholar
21Riazuddin, S, Khan, SN, Ahmed, ZM, Ghosh, M, Caution, K, Nazli, S et al. Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness. Am J Hum Genet 2006;78:137–43Google Scholar
22Shahin, H, Walsh, T, Sobe, T, Abu Sa'ed, J, Abu Rayan, A, Lynch, ED et al. Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss. Am J Hum Genet 2006;78:144–52Google Scholar
23Rehman, AU, Morell, RJ, Belyantseva, IA, Khan, SY, Boger, ET, Shahzad, M et al. Targeted capture and next-generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79. Am J Hum Genet 2010;86:378–88Google Scholar
24Huebner, AK, Gandia, M, Frommolt, P, Maak, A, Wicklein, EM, Thiele, H et al. Nonsense mutations in SMPX, encoding a protein responsive to physical force, result in X-chromosomal hearing loss. Am J Hum Genet 2011;88:621–7Google Scholar
25Schraders, M, Haas, SA, Weegerink, NJ, Oostrik, J, Hu, H, Hoefsloot, LH et al. Next-generation sequencing identifies mutations of SMPX, which encodes the small muscle protein, X-linked, as a cause of progressive hearing impairment. Am J Hum Genet 2011;88:628–34Google Scholar
26Bartles, JR, Wierda, A, Zheng, L. Identification and characterization of espin, an actin-binding protein localized to the F-actin-rich junctional plaques of Sertoli cell ectoplasmic specializations. J Cell Sci 1996;109:1229–39Google Scholar
27Zheng, L, Sekerkova, G, Vranich, K, Tilney, LG, Mugnaini, E, Bartles, JR. The deaf jerker mouse has a mutation in the gene encoding the espin actin-bundling proteins of hair cell stereocilia and lacks espins. Cell 2000;102:377–85CrossRefGoogle Scholar
28Boulouiz, R, Li, Y, Soualhine, H, Abidi, O, Chafik, A, Nurnberg, G et al. A novel mutation in the Espin gene causes autosomal recessive nonsyndromic hearing loss but no apparent vestibular dysfunction in a Moroccan family. Am J Med Genet A 2008;146A:3086–9Google Scholar
29Naz, S, Griffith, AJ, Riazuddin, S, Hampton, LL, Battey, JF Jr, Khan, SN et al. Mutations of ESPN cause autosomal recessive deafness and vestibular dysfunction. J Med Genet 2004;41:591–5Google Scholar
30Donaudy, F, Zheng, L, Ficarella, R, Ballana, E, Carella, M, Melchionda, S et al. Espin gene (ESPN) mutations associated with autosomal dominant hearing loss cause defects in microvillar elongation or organisation. J Med Genet 2006;43:157–61CrossRefGoogle ScholarPubMed
31Pataky, F, Pironkova, R, Hudspeth, AJ. Radixin is a constituent of stereocilia in hair cells. Proc Natl Acad Sci U S A 2004;101:2601–6CrossRefGoogle ScholarPubMed
32Khan, SY, Ahmed, ZM, Shabbir, MI, Kitajiri, S, Kalsoom, S, Tasneem, S et al. Mutations of the RDX gene cause nonsyndromic hearing loss at the DFNB24 locus. Hum Mutat 2007;28:417–23Google Scholar
33Goodyear, RJ, Marcotti, W, Kros, CJ, Richardson, GP. Development and properties of stereociliary link types in hair cells of the mouse cochlea. J Comp Neurol 2005;485:7585Google Scholar
34Mburu, P, Mustapha, M, Varela, A, Weil, D, El-Amraoui, A, Holme, RH et al. Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31. Nat Genet 2003;34:421–8Google Scholar
35Ouyang, XM, Xia, XJ, Verpy, E, Du, LL, Pandya, A, Petit, C et al. Mutations in the alternatively spliced exons of USH1C cause non-syndromic recessive deafness. Hum Genet 2002;111:2630Google Scholar
36Ahmed, ZM, Smith, TN, Riazuddin, S, Makishima, T, Ghosh, M, Bokhari, S et al. Nonsyndromic recessive deafness DFNB18 and Usher syndrome type IC are allelic mutations of USHIC. Hum Genet 2002;110:527–31Google Scholar
37Shabbir, MI, Ahmed, ZM, Khan, SY, Riazuddin, S, Waryah, AM, Khan, SN et al. Mutations of human TMHS cause recessively inherited non-syndromic hearing loss. J Med Genet 2006;43:634–40Google Scholar
38Schraders, M, Oostrik, J, Huygen, PL, Strom, TM, van Wijk, E, Kunst, HP et al. Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction. Am J Hum Genet 2010;86:604–10Google Scholar
39Verpy, E, Masmoudi, S, Zwaenepoel, I, Leibovici, M, Hutchin, TP, Del Castillo, I et al. Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus. Nat Genet 2001;29:345–9Google Scholar
40Zheng, J, Miller, KK, Yang, T, Hildebrand, MS, Shearer, AE, DeLuca, AP et al. Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with alpha-tectorin and is mutated in autosomal dominant hearing loss (DFNA4). Proc Natl Acad Sci U S A 2011;108:4218–23Google Scholar
41Zwaenepoel, I, Mustapha, M, Leibovici, M, Verpy, E, Goodyear, R, Liu, XZ et al. Otoancorin, an inner ear protein restricted to the interface between the apical surface of sensory epithelia and their overlying acellular gels, is defective in autosomal recessive deafness DFNB22. Proc Natl Acad Sci U S A 2002;99:6240–5Google Scholar
42Bork, JM, Peters, LM, Riazuddin, S, Bernstein, SL, Ahmed, ZM, Ness, SL et al. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet 2001;68:2637Google Scholar
43Michalski, N, Michel, V, Caberlotto, E, Lefevre, GM, van Aken, AF, Tinevez, JY et al. Harmonin-b, an actin-binding scaffold protein, is involved in the adaptation of mechanoelectrical transduction by sensory hair cells. Pflugers Arch 2009;459:115–30CrossRefGoogle ScholarPubMed
44Michalski, N, Michel, V, Bahloul, A, Lefevre, G, Barral, J, Yagi, H et al. Molecular characterization of the ankle-link complex in cochlear hair cells and its role in the hair bundle functioning. J Neurosci 2007;27:6478–88Google Scholar
45Goodyear, RJ, Legan, PK, Wright, MB, Marcotti, W, Oganesian, A, Coats, SA et al. A receptor-like inositol lipid phosphatase is required for the maturation of developing cochlear hair bundles. J Neurosci 2003;23:9208–19Google Scholar
46Gillespie, PG, Dumont, RA, Kachar, B. Have we found the tip link, transduction channel, and gating spring of the hair cell? Curr Opin Neurobiol 2005;15:389–96Google Scholar
47Michel, V, Goodyear, RJ, Weil, D, Marcotti, W, Perfettini, I, Wolfrum, U et al. Cadherin 23 is a component of the transient lateral links in the developing hair bundles of cochlear sensory cells. Dev Biol 2005;280:281–94Google Scholar
48Kazmierczak, P, Sakaguchi, H, Tokita, J, Wilson-Kubalek, EM, Milligan, RA, Muller, U et al. Cadherin 23 and protocadherin 15 interact to form tip-link filaments in sensory hair cells. Nature 2007;449:8791Google Scholar
49Xiong, W, Grillet, N, Elledge, HM, Wagner, TF, Zhao, B, Johnson, KR et al. TMHS is an integral component of the mechanotransduction machinery of cochlear hair cells. Cell 2012;151:1283–95Google Scholar
50Verpy, E, Leibovici, M, Michalski, N, Goodyear, RJ, Houdon, C, Weil, D et al. Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. J Comp Neurol 2011;519:194210Google Scholar
51Friedman, LM, Dror, AA, Avraham, KB. Mouse models to study inner ear development and hereditary hearing loss. Int J Dev Biol 2007;51:609–31CrossRefGoogle ScholarPubMed
52Donaudy, F, Ferrara, A, Esposito, L, Hertzano, R, Ben-David, O, Bell, RE et al. Multiple mutations of MYO1A, a cochlear-expressed gene, in sensorineural hearing loss. Am J Hum Genet 2003;72:1571–7Google Scholar
53Walsh, T, Walsh, V, Vreugde, S, Hertzano, R, Shahin, H, Haika, S et al. From flies' eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc Natl Acad Sci U S A 2002;99:7518–23Google Scholar
54Melchionda, S, Ahituv, N, Bisceglia, L, Sobe, T, Glaser, F, Rabionet, R et al. MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am J Hum Genet 2001;69:635–40Google Scholar
55Ahmed, ZM, Morell, RJ, Riazuddin, S, Gropman, A, Shaukat, S, Ahmad, MM et al. Mutations of MYO6 are associated with recessive deafness, DFNB37. Am J Hum Genet 2003;72:1315–22Google Scholar
56Liu, XZ, Walsh, J, Tamagawa, Y, Kitamura, K, Nishizawa, M, Steel, KP et al. Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat Genet 1997;17:268–9CrossRefGoogle ScholarPubMed
57Weil, D, Kussel, P, Blanchard, S, Levy, G, Levi-Acobas, F, Drira, M et al. The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nat Genet 1997;16:191–3Google Scholar
58Lalwani, AK, Goldstein, JA, Kelley, MJ, Luxford, W, Castelein, CM, Mhatre, AN. Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet 2000;67:1121–8Google Scholar
59Donaudy, F, Snoeckx, R, Pfister, M, Zenner, HP, Blin, N, Di Stazio, M et al. Nonmuscle myosin heavy-chain gene MYH14 is expressed in cochlea and mutated in patients affected by autosomal dominant hearing impairment (DFNA4). Am J Hum Genet 2004;74:770–6CrossRefGoogle ScholarPubMed
60Wang, A, Liang, Y, Fridell, RA, Probst, FJ, Wilcox, ER, Touchman, JW et al. Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. Science 1998;280:1447–51Google Scholar
61Heidrych, P, Zimmermann, U, Kuhn, S, Franz, C, Engel, J, Duncker, SV et al. Otoferlin interacts with myosin VI: implications for maintenance of the basolateral synaptic structure of the inner hair cell. Hum Mol Genet 2009;18:2779–90Google Scholar
62Yasunaga, S, Grati, M, Cohen-Salmon, M, El-Amraoui, A, Mustapha, M, Salem, N et al. A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat Genet 1999;21:363–9Google Scholar
63Ruel, J, Emery, S, Nouvian, R, Bersot, T, Amilhon, B, Van Rybroek, JM et al. Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. Am J Hum Genet 2008;83:278–92Google Scholar
64Seal, RP, Akil, O, Yi, E, Weber, CM, Grant, L, Yoo, J et al. Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3. Neuron 2008;57:263–75Google Scholar
65Ben-Yosef, T, Belyantseva, IA, Saunders, TL, Hughes, ED, Kawamoto, K, Van Itallie, CM et al. Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration. Hum Mol Genet 2003;12:2049–61Google Scholar
66Wilcox, ER, Burton, QL, Naz, S, Riazuddin, S, Smith, TN, Ploplis, B et al. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell 2001;104:165–72Google Scholar
67Riazuddin, S, Ahmed, ZM, Fanning, AS, Lagziel, A, Kitajiri, S, Ramzan, K et al. Tricellulin is a tight-junction protein necessary for hearing. Am J Hum Genet 2006;79:1040–51Google Scholar
68Walsh, T, Pierce, SB, Lenz, DR, Brownstein, Z, Dagan-Rosenfeld, O, Shahin, H et al. Genomic duplication and overexpression of TJP2/ZO-2 leads to altered expression of apoptosis genes in progressive nonsyndromic hearing loss DFNA51. Am J Hum Genet 2010;87:101–9Google Scholar
69Lenz, DR, Avraham, KB. Hereditary hearing loss: from human mutation to mechanism. Hear Res 2011;281:310Google Scholar
70Hoang Dinh, E, Ahmad, S, Chang, Q, Tang, W, Stong, B, Lin, X. Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models. Brain Res 2009;1277:5269Google Scholar
71Kelsell, DP, Dunlop, J, Stevens, HP, Lench, NJ, Liang, JN, Parry, G et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997;387:80–3Google Scholar
72Xia, JH, Liu, CY, Tang, BS, Pan, Q, Huang, L, Dai, HP et al. Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment. Nat Genet 1998;20:370–3Google Scholar
73Liu, XZ, Xia, XJ, Xu, LR, Pandya, A, Liang, CY, Blanton, SH et al. Mutations in connexin 31 underlie recessive as well as dominant non-syndromic hearing loss. Hum Mol Genet 2000;9:63–7Google Scholar
74Grifa, A, Wagner, CA, D'Ambrosio, L, Melchionda, S, Bernardi, F, Lopez-Bigas, N et al. Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet 1999;23:1618Google Scholar
75del Castillo, I, Villamar, M, Moreno-Pelayo, MA, del Castillo, FJ, Alvarez, A, Telleria, D et al. A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. N Engl J Med 2002;346:243–9CrossRefGoogle ScholarPubMed
76Kubisch, C, Schroeder, BC, Friedrich, T, Lutjohann, B, El-Amraoui, A, Marlin, S et al. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 1999;96:437–46Google Scholar
77Heidenreich, M, Lechner, SG, Vardanyan, V, Wetzel, C, Cremers, CW, De Leenheer, EM et al. KCNQ4 K(+) channels tune mechanoreceptors for normal touch sensation in mouse and man. Nat Neurosci 2011;15:138–45CrossRefGoogle ScholarPubMed
78Schultz, JM, Yang, Y, Caride, AJ, Filoteo, AG, Penheiter, AR, Lagziel, A et al. Modification of human hearing loss by plasma-membrane calcium pump PMCA2. N Engl J Med 2005;352:1557–64Google Scholar
79Bortolozzi, M, Brini, M, Parkinson, N, Crispino, G, Scimemi, P, De Siati, RD et al. The novel PMCA2 pump mutation Tommy impairs cytosolic calcium clearance in hair cells and links to deafness in mice. J Biol Chem 2010;285:37693–703Google Scholar
80Riazuddin, S, Anwar, S, Fischer, M, Ahmed, ZM, Khan, SY, Janssen, AG et al. Molecular basis of DFNB73: mutations of BSND can cause nonsyndromic deafness or Bartter syndrome. Am J Hum Genet 2009;85:273–80CrossRefGoogle ScholarPubMed
81Li, XC, Everett, LA, Lalwani, AK, Desmukh, D, Friedman, TB, Green, ED et al. A mutation in PDS causes non-syndromic recessive deafness. Nat Genet 1998;18:215–17Google Scholar
82Everett, LA, Glaser, B, Beck, JC, Idol, JR, Buchs, A, Heyman, M et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997;17:411–22Google Scholar
83Zheng, J, Shen, W, He, DZ, Long, KB, Madison, LD, Dallos, P. Prestin is the motor protein of cochlear outer hair cells. Nature 2000;405:149–55Google Scholar
84Liberman, MC, Gao, J, He, DZ, Wu, X, Jia, S, Zuo, J. Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier. Nature 2002;419:300–4CrossRefGoogle ScholarPubMed
85Liu, XZ, Ouyang, XM, Xia, XJ, Zheng, J, Pandya, A, Li, F et al. Prestin, a cochlear motor protein, is defective in non-syndromic hearing loss. Hum Mol Genet 2003;12:1155–62Google Scholar
86Brown, SD, Hardisty-Hughes, RE, Mburu, P. Quiet as a mouse: dissecting the molecular and genetic basis of hearing. Nat Rev Genet 2008;9:277–90Google Scholar
87Hardisty-Hughes, RE, Parker, A, Brown, SD. A hearing and vestibular phenotyping pipeline to identify mouse mutants with hearing impairment. Nat Protoc 2010;5:177–90Google Scholar
Figure 0

Table I Genes associated with non-syndromic hearing loss

Figure 1

Fig. 1 Anatomical diagrams of the human ear, showing: (a) the outer ear, middle ear and inner ear; (b) a cross section of the cochlea; (c) the three compartments of the cochlea; and (d) the organ of Corti. OHC = outer hair cell

Figure 2

Fig. 2 Diagrammatic representation of important structural proteins in mature hair cell stereocilia. CEACAM16 = carcinogenic antigen-related cell adhesion molecule 16; TRIOBP = trio-binding protein; SMPX = small muscle protein, X-linked; TMC = tectorial membrane attachment crown; TL = tip link; HT = horizontal top connector

Figure 3

Fig. 3 Diagrammatic representation of potassium circulation within the cochlea: the opening of ion channels in the hair cell apical membrane allows a potassium influx from the endolymph into the hair cell; potassium is then moved to supporting cells and pumped back into the endolymph via spiral ligament and stria vascularis gap junction networks. K+ = potassium ion; IHC = inner hair cells; OHC = outer hair cells